Columbia Banking System: Strong Buy As Contrarian EPS Inflection Drives Upside

Moretus Research initiates coverage of Columbia Banking System (COLB) with a Strong Buy rating and a $40 price target, representing a 73% upside. The firm anticipates a significant EPS rebound of 36% to $3.40 in FY26E, driven by synergy capture from the Pacific Premier merger, despite an expected dip in FY25E EPS due to M&A-related charges. This valuation is based on an 11.7x forward P/E multiple on the FY26E EPS estimate, however, delayed synergy capture or credit deterioration could impede the anticipated earnings recovery.

Analysis

Moretus Research has initiated coverage on Columbia Banking System, Inc. (NASDAQ:COLB) with a Strong Buy rating and a $40 price target, implying a potential 73% upside from current levels. This valuation is predicated on a forward P/E multiple of 11.7x applied to Moretus Research's 2026 earnings per share (EPS) estimate of $3.40. The firm's outlook anticipates a material decrease in FY25E EPS, attributed to M&A charges and accounting provisions related to the Pacific Premier merger. However, a significant EPS rebound of 36% is projected for FY26E, reaching $3.40, which is notably 11% above consensus estimates. This sharp earnings inflection in 2026, driven by expected synergy capture from the merger, is identified as a key factor potentially mispriced by the market. The primary risks to this forecast include a delay in realizing these synergies or an unforeseen deterioration in credit quality, either of which could postpone or diminish the anticipated earnings recovery.

Key Decisions for Investors

• Investors should consider the potential for significant share price appreciation given Moretus Research's $40 price target and the contrarian view on the 2026 EPS inflection for Columbia Banking System.
• Monitor the integration progress and synergy realization from the Pacific Premier merger, as this is a critical driver for the projected 36% EPS rebound in FY26E.
• Closely track credit quality indicators for Columbia Banking System, as unexpected deterioration poses a key risk to the earnings recovery thesis and could impact the stock's performance.
• Evaluate the potential for a temporary dip in FY25E EPS due to M&A-related charges, understanding that the core investment thesis hinges on a substantial recovery and growth in FY26E.